Journal
EUROPEAN JOURNAL OF PHARMACOLOGY
Volume 779, Issue -, Pages 91-101Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejphar.2016.03.016
Keywords
Ca2+ homeostasis; Intracellular Ca2+ concentration; Na+-Ca2+ exchanger; Ryanodine receptor; Heart failure; Cardiac arrhythmia
Categories
Funding
- European Union
- State of Hungary
- European Social Fund [TAMOP-4.2.4.A/2-11/1-2012-0001]
- Hungarian Scientific Research Fund [OTKA] [ANN-113273, K115397]
Ask authors/readers for more resources
Abnormal Ca2+ homeostasis is often associated with chronic cardiovascular diseases, such as hypertension, heart failure or cardiac arrhythmias, and typically contributes to the basic ethiology of the disease. Pharmacological targeting of cardiac Ca2+ handling has great therapeutic potential offering invaluable options for the prevention, slowing down the progression or suppression of the harmful outcomes like life threatening cardiac arrhythmias. In this review we outline the existing knowledge on the involvement of malfunction of the ryanodine receptor and the Na+-Ca2+ exchanger in disturbances of Ca2+ homeostasis and discuss important proof of concept pharmacological studies targeting these mechanisms in context of hypertension, heart failure, atrial fibrillation and ventricular arrhythmias. We emphasize the promising results of preclinical studies underpinning the potential benefits of the therapeutic strategies based on ryanodine receptor or Na+-Ca2+ exchanger inhibition. (C) 2016 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available